Skip to main content

Find Clinical Trials

Home
Conditions
Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)

Clinical trial condition

Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)

Explore clinical trials studying Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2) trial results

Completed

Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2

NCT03338348

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Kliniken Essen-Süd, Evang. Krankenhaus Essen-Werden gGmbH Essen, Germany

Klinikum Oldenburg, Klinik für Innere Medizin II Oldenburg, Germany

University Hospital Ulm Ulm, Germany

View Trial Details